Table 1: Genetic factors implicated in PCOS with relevance to consanguinity.
|
Gene/Locus |
Known Role in PCOS |
Relevance to Consanguinity/Autozygosity |
|
DENND1A |
Hyperandrogenism, gonadotropin exocytosis, ovarian function |
Part of polygenic risk, variants associated with PCOS susceptibility in various ethnicities |
|
THADA |
Energy metabolism, obesity, insulin resistance |
Part of polygenic risk, associated with dysfunctions in energy metabolism |
|
LHCGR |
Luteinizing hormone/choriogonadotropi n receptor, ovarian function, androgen secretion |
Part of polygenic risk, overexpression in PCOS |
|
FSHR |
Follicle-stimulating hormone receptor, ovarian function |
Part of polygenic risk, variants investigated for PCOS susceptibility |
|
INSR |
Insulin receptor, insulin resistance, ovarian androgen production |
Part of polygenic risk, under expression in metabolic tissues, overexpression in ovary |
|
BRCA1 |
DNA repair, tumor suppressor, ovarian function |
Specific association with PCOS in consanguineous cohorts, potential influence on ovarian dysfunction |
|
CYP11a |
Steroidogenesis (cholesterol to progesterone) |
Reported association with PCOS, though replication varies |
|
CYP21 |
Steroidogenesis (17- hydroxyprogesterone to 11- deoxycortisol) |
Heterozygous association with PCOS- like hyperandrogenemia |
|
CYP17 |
Steroidogenesis (pregnenolone/progesterone to 17-hydroxy forms), androgen levels |
Increased expression in theca cells, polymorphism associated with PCOS |
|
CYP19 |
Aromatase p450, estrogen formation |
Lower activity reported in PCOS |
|
AR |
Androgen receptor, androgen effects |
Mutations/disruptions reported to cause PCOS, on X chromosome |
|
SHBG |
Sex hormone-binding globulin, controls sex hormone levels |
Lower in PCOS due to hyperinsulinemia, variants investigated |
|
CD93, CYBB, DOCK8, IRF1, MBOAT1, MYO1F, NLRP1, NOD2, PIK3R1, PTER |
Various roles (e.g., cytokine production, TNF signaling) |
Identified as "hub genes" in recent bioinformatics analyses, causal relationship with PCOS risk |